These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2979265)

  • 81. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease.
    Marino G; Rustgi VK; Salzberg G; Johnson LB; Kuo PC; Plotkin JS; Flockhart DA
    Aliment Pharmacol Ther; 2002 Feb; 16(2):235-42. PubMed ID: 11860406
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prescribing for patients with liver disease.
    Arns PA; Branch RA
    Baillieres Clin Gastroenterol; 1989 Jan; 3(1):109-30. PubMed ID: 2655746
    [No Abstract]   [Full Text] [Related]  

  • 84. Safe use of proton pump inhibitors in patients with cirrhosis.
    Weersink RA; Bouma M; Burger DM; Drenth JPH; Harkes-Idzinga SF; Hunfeld NGM; Metselaar HJ; Monster-Simons MH; van Putten SAW; Taxis K; Borgsteede SD
    Br J Clin Pharmacol; 2018 Aug; 84(8):1806-1820. PubMed ID: 29688583
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effects of liver disease on pharmacokinetics. An update.
    Rodighiero V
    Clin Pharmacokinet; 1999 Nov; 37(5):399-431. PubMed ID: 10589374
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetics of intravenous omeprazole in children.
    Jacqz-Aigrain E; Bellaich M; Faure C; Andre J; Rohrlich P; Baudouin V; Navarro J
    Eur J Clin Pharmacol; 1994; 47(2):181-5. PubMed ID: 7859807
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical pharmacology of omeprazole.
    Howden CW
    Clin Pharmacokinet; 1991 Jan; 20(1):38-49. PubMed ID: 2029801
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Omeprazole. Overview and opinion.
    Holt S; Howden CW
    Dig Dis Sci; 1991 Apr; 36(4):385-93. PubMed ID: 2007354
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D; Buckley MM; Heel RC
    Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effect of omeprazole on gastric acid secretion and plasma gastrin.
    Olbe L; Cederberg C; Lind T; Olausson M
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Omeprazole and liver functions].
    Sauvet P; Schouler L
    Rev Med Interne; 1992; 13(5):359-63. PubMed ID: 1344831
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The anti-secretory effect and pharmacokinetics of omeprazole in chronic liver disease.
    McKee RF; MacGilchrist AJ; Garden OJ; Forrest JA; Carter DC
    Aliment Pharmacol Ther; 1988 Oct; 2(5):429-37. PubMed ID: 2979265
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
    Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
    Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.
    Andersson T; Röhss K; Bredberg E; Hassan-Alin M
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1563-9. PubMed ID: 11563995
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.
    Jansen JB; Lundborg P; Baak LC; Greve J; Ohman M; Stöver C; Röhss K; Lamers CB
    Gut; 1988 Jan; 29(1):75-80. PubMed ID: 3343017
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.